Yasutaka Chiba Selected Research

Morphine (MS Contin)

8/2023	Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.
1/2023	Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
10/2017	Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasutaka Chiba Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 07/2011
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 08/2010
7	Stomach Neoplasms (Stomach Cancer) 07/2020 - 12/2012
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2012
4	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 06/2011
4	Pain (Aches) 08/2023 - 09/2017
4	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2016
4	Lung Neoplasms (Lung Cancer) 01/2023 - 05/2016
3	Cancer Pain 08/2023 - 10/2017
3	Esophageal Squamous Cell Carcinoma 04/2023 - 01/2019
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 08/2013
3	Pathologic Constriction (Stenosis) 01/2018 - 11/2016
2	Adenocarcinoma 11/2023 - 07/2019
2	Vomiting 01/2023 - 01/2020
2	Nausea 01/2023 - 01/2020
2	Obstructive Jaundice (Cholestatic Jaundice) 11/2022 - 02/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2019
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 10/2020 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2020 - 12/2015
2	Asthma (Bronchial Asthma) 07/2020 - 03/2013
2	Osteoporosis 11/2019 - 06/2015
2	Duodenal Obstruction 02/2016 - 02/2016
2	Cholestasis 02/2016 - 02/2016
2	Insulin Resistance 06/2015 - 01/2015
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Neoplasm Micrometastasis 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2015
8	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2017
8	NivolumabIBA 01/2023 - 11/2017
8	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2015
6	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 10/2018
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 05/2012
5	LigandsIBA 08/2023 - 01/2015
5	Docetaxel (Taxotere)FDA Link 04/2023 - 01/2019
5	AfatinibIBA 01/2023 - 11/2017
4	Immune Checkpoint InhibitorsIBA 04/2024 - 03/2018
4	Carboplatin (JM8)FDA LinkGeneric 03/2022 - 07/2011
3	Immune Checkpoint ProteinsIBA 04/2024 - 01/2018
3	B7-H1 AntigenIBA 04/2024 - 01/2022
3	Opioid Analgesics (Opioids)IBA 08/2023 - 10/2017
3	Oxycodone (Oxycontin)FDA LinkGeneric 08/2023 - 10/2017
3	Morphine (MS Contin)FDA LinkGeneric 08/2023 - 10/2017
3	Fluorouracil (Carac)FDA LinkGeneric 04/2023 - 01/2019
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 06/2011
3	osimertinibIBA 01/2023 - 02/2019
3	Neuregulin-1 (Neuregulin 1)IBA 12/2019 - 01/2015
2	durvalumabIBA 03/2024 - 10/2023
2	130-nm albumin-bound paclitaxelIBA 09/2023 - 01/2021
2	Gemcitabine FDA Link 09/2023 - 12/2021
2	AntigensIBA 01/2023 - 01/2022
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023 - 10/2017
2	pembrolizumabIBA 01/2023 - 10/2021
2	Pemetrexed (MTA)FDA Link 03/2022 - 11/2017
2	Oxygen (Dioxygen)IBA 10/2020 - 12/2015
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 06/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019 - 11/2017
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	Immunologic Factors (Immunomodulators)IBA 04/2024
1	trifluridine tipiracil drug combinationIBA 11/2023
1	Bevacizumab (Avastin)FDA Link 11/2023
1	ChemokinesIBA 08/2023
1	Analgesics (Analgesic Drugs)IBA 08/2023
1	Histamine N-MethyltransferaseIBA 08/2023
1	AntiemeticsIBA 01/2023
1	Olanzapine (Zyprexa)FDA Link 01/2023
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	PlasticsIBA 11/2022
1	MetalsIBA 11/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	patritumab deruxtecanIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Cancer VaccinesIBA 01/2022
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2022
1	UracilIBA 12/2021
1	TegafurIBA 12/2021
1	perfluorobutane (AI 700)IBA 01/2021

Therapy/Procedure

23	Therapeutics 04/2024 - 07/2012
15	Drug Therapy (Chemotherapy) 11/2023 - 08/2010
9	Stents 11/2022 - 02/2016
6	Radiotherapy 06/2021 - 08/2010
4	Chemoradiotherapy 03/2024 - 05/2012
4	Neoadjuvant Therapy 04/2023 - 01/2019
2	Immunotherapy 01/2019 - 01/2018
2	TP protocol 10/2018 - 10/2018
2	Duration of Therapy 09/2017 - 06/2011
2	Choledochostomy 02/2016 - 02/2016
1	Adjuvant Chemotherapy 04/2024
1	Colectomy 01/2023
1	Palliative Care (Palliative Therapy) 01/2023
1	Self Expandable Metallic Stents 01/2021